CN110753845B - 用于实体瘤诊断的生物标志物绝对定量的方法和装置 - Google Patents

用于实体瘤诊断的生物标志物绝对定量的方法和装置 Download PDF

Info

Publication number
CN110753845B
CN110753845B CN201880039041.8A CN201880039041A CN110753845B CN 110753845 B CN110753845 B CN 110753845B CN 201880039041 A CN201880039041 A CN 201880039041A CN 110753845 B CN110753845 B CN 110753845B
Authority
CN
China
Prior art keywords
sample
marker
analysis
qdb
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201880039041.8A
Other languages
English (en)
Chinese (zh)
Other versions
CN110753845A (zh
Inventor
张建棣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yantai Zestern Biotechnique Co ltd
Original Assignee
Quanticision Diagnostics Inc
Yantai Zestern Biotechnique Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quanticision Diagnostics Inc, Yantai Zestern Biotechnique Co ltd filed Critical Quanticision Diagnostics Inc
Publication of CN110753845A publication Critical patent/CN110753845A/zh
Application granted granted Critical
Publication of CN110753845B publication Critical patent/CN110753845B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN201880039041.8A 2017-06-29 2018-06-28 用于实体瘤诊断的生物标志物绝对定量的方法和装置 Active CN110753845B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762526425P 2017-06-29 2017-06-29
US62/526,425 2017-06-29
PCT/US2018/040075 WO2019006156A1 (en) 2017-06-29 2018-06-28 APPARATUS AND METHOD FOR ABSOLUTE QUANTIFICATION OF BIOMARKERS FOR SOLID TUMOR DIAGNOSIS

Publications (2)

Publication Number Publication Date
CN110753845A CN110753845A (zh) 2020-02-04
CN110753845B true CN110753845B (zh) 2023-08-22

Family

ID=64734814

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880039041.8A Active CN110753845B (zh) 2017-06-29 2018-06-28 用于实体瘤诊断的生物标志物绝对定量的方法和装置

Country Status (8)

Country Link
US (2) US10788484B2 (enExample)
EP (1) EP3646328A4 (enExample)
JP (1) JP7194128B2 (enExample)
KR (1) KR102502745B1 (enExample)
CN (1) CN110753845B (enExample)
CA (1) CA3101968A1 (enExample)
SG (1) SG11201908865WA (enExample)
WO (1) WO2019006156A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX357763B (es) 2013-10-18 2018-07-23 Univ Health Network Tratamiento para cancer pancreatico.
SG11201808629UA (en) * 2016-04-21 2018-11-29 Immatics Biotechnologies Gmbh Immunotherapy against melanoma and other cancers
DE102016209871A1 (de) 2016-06-06 2017-12-07 Robert Bosch Gmbh Stanzvorrichtung und Verfahren zum Stanzen eines Lumens und Implantieren einer Implantateinrichtung
DE102018201030B4 (de) * 2018-01-24 2025-10-16 Kardion Gmbh Magnetkuppelelement mit magnetischer Lagerungsfunktion
DE102018206750A1 (de) 2018-05-02 2019-11-07 Kardion Gmbh Vorrichtung zur induktiven Energieübertragung in einen menschlichen Körper und deren Verwendung
DE102018206754A1 (de) 2018-05-02 2019-11-07 Kardion Gmbh Verfahren und Vorrichtung zur Bestimmung der Temperatur an einer Oberfläche sowie Verwendung des Verfahrens
DE102018206725A1 (de) 2018-05-02 2019-11-07 Kardion Gmbh Empfangseinheit, Sendeeinheit, Energieübertragungssystem und Verfahren zur drahtlosen Energieübertragung
DE102018206727A1 (de) 2018-05-02 2019-11-07 Kardion Gmbh Energieübertragungssystem und Empfangseinheit zur drahtlosen transkutanen Energieübertragung
DE102018206724A1 (de) 2018-05-02 2019-11-07 Kardion Gmbh Energieübertragungssystem und Verfahren zur drahtlosen Energieübertragung
DE102018206731A1 (de) 2018-05-02 2019-11-07 Kardion Gmbh Vorrichtung zur induktiven Energieübertragung in einen menschlichen Körper und Verwendung der Vorrichtung
DE102018207611A1 (de) 2018-05-16 2019-11-21 Kardion Gmbh Rotorlagerungssystem
DE102018207575A1 (de) 2018-05-16 2019-11-21 Kardion Gmbh Magnetische Stirndreh-Kupplung zur Übertragung von Drehmomenten
DE102018208539A1 (de) 2018-05-30 2019-12-05 Kardion Gmbh Motorgehäusemodul zum Abdichten eines Motorraums eines Motors eines Herzunterstützungssystems und Herzunterstützungssystem und Verfahren zum Montieren eines Herzunterstützungssystems
DE102018208538A1 (de) 2018-05-30 2019-12-05 Kardion Gmbh Intravasale Blutpumpe und Verfahren zur Herstellung von elektrischen Leiterbahnen
DE102018208541A1 (de) 2018-05-30 2019-12-05 Kardion Gmbh Axialpumpe für ein Herzunterstützungssystem und Verfahren zum Herstellen einer Axialpumpe für ein Herzunterstützungssystem
DE102018208549A1 (de) 2018-05-30 2019-12-05 Kardion Gmbh Elektronikmodul für ein Herzunterstützungssystem und Verfahren zum Herstellen eines Elektronikmoduls für ein Herzunterstützungssystem
DE102018208550A1 (de) 2018-05-30 2019-12-05 Kardion Gmbh Leitungsvorrichtung zum Leiten eines Blutstroms für ein Herzunterstützungssystem, Herzunterstützungssystem und Verfahren zum Herstellen einer Leitungsvorrichtung
DE102018208555A1 (de) 2018-05-30 2019-12-05 Kardion Gmbh Vorrichtung zum Verankern eines Herzunterstützungssystems in einem Blutgefäß, Verfahren zum Betreiben und Herstellverfahren zum Herstellen einer Vorrichtung und Herzunterstützungssystem
DE102018210076A1 (de) 2018-06-21 2019-12-24 Kardion Gmbh Verfahren und Vorrichtung zum Erkennen eines Verschleißzustands eines Herzunterstützungssystems, Verfahren und Vorrichtung zum Betreiben eines Herzunterstützungssystems und Herzunterstützungssystem
DE102018210058A1 (de) 2018-06-21 2019-12-24 Kardion Gmbh Statorschaufelvorrichtung zur Strömungsführung eines aus einer Austrittsöffnung eines Herzunterstützungssystems ausströmenden Fluids, Herzunterstützungssystem mit Statorschaufelvorrichtung, Verfahren zum Betreiben einer Statorschaufelvorrichtung und Herstellverfahren
EP3818496A4 (en) * 2018-07-02 2022-04-20 Tempus Labs, Inc. 3D RADIOMICS PLATFORM FOR IMAGING BIOMARKER DEVELOPMENT
DE102018211297A1 (de) 2018-07-09 2020-01-09 Kardion Gmbh Herzunterstützungssystem und Verfahren zur Überwachung der Integrität einer Haltestruktur eines Herzunterstützungssystems
DE102018211327A1 (de) 2018-07-10 2020-01-16 Kardion Gmbh Laufrad für ein implantierbares, vaskuläres Unterstützungssystem
DE102018211328A1 (de) 2018-07-10 2020-01-16 Kardion Gmbh Laufradgehäuse für ein implantierbares, vaskuläres Unterstützungssystem
DE102018212153A1 (de) 2018-07-20 2020-01-23 Kardion Gmbh Zulaufleitung für eine Pumpeneinheit eines Herzunterstützungssystems, Herzunterstützungssystem und Verfahren zum Herstellen einer Zulaufleitung für eine Pumpeneinheit eines Herzunterstützungssystems
AU2019320533B2 (en) 2018-08-07 2024-11-21 Kardion Gmbh Bearing device for a cardiac support system, and method for flushing an intermediate space in a bearing device for a cardiac support system
CN114631027A (zh) * 2019-11-01 2022-06-14 烟台康体诊医疗科技有限公司 基于定量生物标志物的癌症诊断方法及其数据库
AU2021207312A1 (en) * 2020-01-17 2022-06-30 Universität Zürich Single cell pathology analysis of tumour samples
DE102020102474A1 (de) 2020-01-31 2021-08-05 Kardion Gmbh Pumpe zum Fördern eines Fluids und Verfahren zum Herstellen einer Pumpe
US11699551B2 (en) 2020-11-05 2023-07-11 Kardion Gmbh Device for inductive energy transmission in a human body and use of the device

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1675550A (zh) * 2002-08-01 2005-09-28 Mtm实验室公司 基于溶液的检测方法
CN103562409A (zh) * 2011-05-25 2014-02-05 诺华股份有限公司 肺癌的生物标志物
WO2016172216A1 (en) * 2015-04-20 2016-10-27 The Methodist Hospital Use of soluble crkl compositions as breast cancer biomarkers and predictors of cancer metastasis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003252235A1 (en) * 2002-07-25 2004-02-16 Ajinomoto Co., Inc. Method of analyzing protein
DE102005023011A1 (de) * 2005-05-19 2006-11-23 Qiagen Gmbh Quantitative Proteinbestimmung von Formalin fixiertem Gewebe
CA2653398A1 (en) * 2006-05-26 2007-12-06 Board Of Regents, The University Of Texas System Reverse phase protein array, protein activation and expression signatures, and associated methods
GB0611669D0 (en) * 2006-06-13 2006-07-19 Astrazeneca Uk Ltd Mass spectrometry biomarker assay
JPWO2008075664A1 (ja) * 2006-12-21 2010-04-15 味の素株式会社 癌の評価方法、ならびに癌評価装置、癌評価方法、癌評価システム、癌評価プログラムおよび記録媒体
US8771962B2 (en) * 2008-10-02 2014-07-08 Sarka O. Southern Health test for a broad spectrum of health problems
EP2239675A1 (en) 2009-04-07 2010-10-13 BIOCRATES Life Sciences AG Method for in vitro diagnosing a complex disease
JP2013099253A (ja) * 2010-03-11 2013-05-23 Intec Systems Institute Inc 肺癌または子宮頸癌の診断マーカー
US8293487B1 (en) * 2012-01-06 2012-10-23 Jiandi Zhang Zestern, a simple, fast, specific and quantifiable improvement of immunodetection process
US9933418B2 (en) * 2015-05-26 2018-04-03 Quanticision Diagnostics Inc. Multi-unit plate for electroblotting and immunoblot analysis
IL294138A (en) * 2015-05-29 2022-08-01 Genentech Inc Therapeutic and diagnostic methods for cancer
EP3465200A4 (en) * 2016-06-05 2020-07-08 Berg LLC PATIENT STRATIFICATION SYSTEMS AND METHODS AND IDENTIFICATION OF POTENTIAL BIOMARKERS

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1675550A (zh) * 2002-08-01 2005-09-28 Mtm实验室公司 基于溶液的检测方法
CN103562409A (zh) * 2011-05-25 2014-02-05 诺华股份有限公司 肺癌的生物标志物
WO2016172216A1 (en) * 2015-04-20 2016-10-27 The Methodist Hospital Use of soluble crkl compositions as breast cancer biomarkers and predictors of cancer metastasis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping;Julia D. Wulfkuhle1 等;《CLINICAL CANCER RESEARCH》;20121201;第18卷(第23期);第1-21页 *

Also Published As

Publication number Publication date
CA3101968A1 (en) 2019-01-03
KR20200020906A (ko) 2020-02-26
US20190004037A1 (en) 2019-01-03
SG11201908865WA (en) 2019-10-30
EP3646328A4 (en) 2021-04-21
JP7194128B2 (ja) 2022-12-21
EP3646328A1 (en) 2020-05-06
US20210011010A1 (en) 2021-01-14
JP2020526747A (ja) 2020-08-31
CN110753845A (zh) 2020-02-04
WO2019006156A1 (en) 2019-01-03
US10788484B2 (en) 2020-09-29
KR102502745B1 (ko) 2023-02-23

Similar Documents

Publication Publication Date Title
CN110753845B (zh) 用于实体瘤诊断的生物标志物绝对定量的方法和装置
Caron et al. Cancer immunomics using autoantibody signatures for biomarker discovery
Brennan et al. Antibody-based proteomics: fast-tracking molecular diagnostics in oncology
US20080254481A1 (en) Methods and kits for detecting prostate cancer biomarkers
Ghods et al. High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma
JP6104796B2 (ja) 方法、アレイ、およびこれらの使用
US20120295814A1 (en) CA-125 Immune Complexes as Biomarkers of Ovarian Cancer
CN102326080A (zh) A+生物标志物的试验
WO2010122846A1 (ja) 癌の組織型を判別するカクテル抗体、判別キット及び判別方法
EP3861348A1 (en) Biomarker combinations for determining aggressive prostate cancer
CN109975549B (zh) 肿瘤来源IgG在胰腺癌诊断或预后中的用途
Li et al. Comparison of 2 anti-PLA2R immunoassays for the diagnosis of primary membranous nephropathy
Kang et al. Electrophoretic cytopathology resolves ERBB2 forms with single-cell resolution
DK2551673T3 (en) Methods for detecting cancer infiltration in the central nervous system
Sanchez et al. Performance of HER2 DAKO HercepTest and Ventana 4B5 immunohistochemical assays on detecting HER2 gene-amplification in uterine serous carcinomas
JP2018520366A (ja) 前立腺疾患のためのバイオマーカーの組み合わせ
Sarli et al. Relationship study of the verified human epidermal growth factor receptor 2 amplification with other tumor markers and clinicohistopathological characteristics in patients with invasive breast cancer, using chromogenic in situ hybridization
Caiazzo Jr et al. Autoantibody microarrays for biomarker discovery
Hanash et al. Deciphering the complexity of the cancer proteome for diagnostic applications
JP5130465B2 (ja) 肝細胞癌マーカー及び肝細胞癌の検査方法
RU2741245C1 (ru) Способ ранней диагностики почечно-клеточной карциномы по наличию белка зрительного аррестина в сыворотке крови
US20250271434A1 (en) Method for predicting prognosis of breast cancer patient using ctc expressing c-met
Bogen et al. Recent trends and advances in immunodiagnostics of solid tumors
CN111208304B (zh) 肿瘤来源IgG在甲状旁腺癌诊断和预后中的用途
JP7154523B2 (ja) 子宮肉腫診断のための迅速測定法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20230609

Address after: 264670 No. 39 Science and Technology Avenue, Yantai High-tech Zone, Shandong Province

Applicant after: YANTAI ZESTERN BIOTECHNIQUE CO.,LTD.

Address before: 264003 Baiwei international building, No. 1295, Gangcheng East Street, Laishan District, Yantai City, Shandong Province

Applicant before: QUANTICISION DIAGNOSTICS Inc.

TA01 Transfer of patent application right
GR01 Patent grant
GR01 Patent grant